| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 59.766 | 82.704 | 81.817 | 67.755 | 48.725 | 78.864 | 2.994 | 0 | 0 | 79.691 |
| Total Income - EUR | 67.535 | 87.895 | 90.064 | 67.755 | 52.202 | 78.864 | 2.997 | 0 | 0 | 79.852 |
| Total Expenses - EUR | 56.593 | 61.518 | 64.600 | 49.014 | 45.802 | 33.854 | 3.752 | 0 | 0 | 74.164 |
| Gross Profit/Loss - EUR | 10.942 | 26.377 | 25.464 | 18.741 | 6.400 | 45.010 | -755 | 0 | 0 | 5.689 |
| Net Profit/Loss - EUR | 9.135 | 25.550 | 24.432 | 18.064 | 5.878 | 44.222 | -787 | 0 | 0 | 4.606 |
| Employees | 3 | 3 | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Davconsib Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.002 | 17.038 | 7.060 | 3.016 | 2.310 | 2.111 | 1.259 | 1.262 | 1.259 | 2.356 |
| Current Assets | 7.566 | 27.714 | 33.996 | 38.331 | 33.307 | 47.438 | 503 | 505 | 503 | 44.159 |
| Inventories | 3.641 | 110 | 0 | 0 | 3.467 | 0 | 0 | 0 | 0 | 86 |
| Receivables | 2.458 | 16.401 | 16.417 | 8.329 | 16.864 | 46.791 | 193 | 194 | 193 | 31.102 |
| Cash | 1.467 | 11.203 | 17.579 | 30.002 | 12.976 | 647 | 310 | 311 | 310 | 12.970 |
| Shareholders Funds | 9.301 | 25.604 | 33.473 | 35.337 | 23.714 | 44.271 | -3.433 | -3.444 | -3.434 | 1.192 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.996 | 19.148 | 7.583 | 6.010 | 11.903 | 5.278 | 5.195 | 5.211 | 5.196 | 45.513 |
| Income in Advance | 13.270 | 8.389 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Davconsib Srl